What is Glaukos Corp (GKOS)?
Glaukos Corp is a medical technology company specializing in the development and commercialization of innovative therapies for the treatment of glaucoma and other eye diseases. The company focuses on minimally invasive surgical devices designed to reduce intraocular pressure and preserve vision. Its product portfolio includes microstent implants and related delivery systems used by ophthalmologists. Glaukos engages in research and development to advance treatment options and improve patient outcomes in ophthalmology. The company collaborates with healthcare professionals and regulatory agencies to ensure product safety and efficacy. It operates within the medical device industry, adhering to regulatory standards for medical product manufacturing and clinical evaluation. Glaukos is governed by a board of directors and emphasizes compliance with healthcare regulations and quality management systems.
Glaukos Corp Stock Price Today: Live Overview
The price today is shaped by the latest activity in Koppers Holdings Inc, trading now at $109.11. Prices have fluctuated between $104.7 and $108.64 during the day, with a daily change of +2.696%.
FAQ: Glaukos Corp (GKOS)
What is the current price of GKOS stock?
Glaukos Corp's current price is $109.11.
Does GKOS pay dividends?
Glaukos Corp does not currently pay dividends.
Does GKOS have a formal corporate presence or regional headquarters in the UAE?
Glaukos Corp operates in the UAE exclusively via partners and distributors without an official office.
What is GKOS best known for?
The company is most famous for developing innovative ophthalmic surgical devices.
What assets are typically shown together with GKOS?
Commonly shown alongside GKOS: ProShares Short S&P500, Open Text Corporation, WAM Capital
Latest shares articles



